Interferon-γ release assays: What is their role in the diagnosis of active tuberculosis?

Clinical Infectious Diseases

Volumn 44, Issue 1, 2007, Pages 74-77

  Pai, Madhukar ^a,b   Menzies, Dick ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ASSAY; CYTOKINE RELEASE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; NOTE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; CHILD; HUMANS; INTERFERON TYPE II; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 33845719534     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/509927     Document Type: Note

References (27)

1. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker, 2000:279-322.
2. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4:761-76.
3. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6:413-22.
4. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 2005; 11:195-202.
5. Dewan P, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-7 release assay for detection of active tuberculosis. Clin Infect Dis 2006; 44:69-73 (in this issue).
6. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64.
7. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172:631-5.
8. Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12:491-6.
9. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
10. Pai M, Joshi R, Dogra S, et al. Preliminary results from an evaluation of a whole-blood, interferon-gamma assay in individuals with tuberculosis infection and disease in a rural Indian hospital. Int J Tuberc Lung Dis 2005; 9:S262.
11. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28:24-30.
12. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367:1328-34.
13. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 2006; 44:2844-50.
14. Goletti D, Carrara S, Vincenti D, et al. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 2006; 12:544-50.
15. Mahomed H, Hughes EJ, Hawkridge T, et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10:310-6.
16. Doherty TM, Demissie A, Menzies D, Andersen P, Rook G, Zumla A. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J Immunol Methods 2005;298:129-41.
17. Pai M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 2006; 10:942-3.
18. Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971; 285:1506-9.
19. Howard WL, Klopfenstein MD, Steininger WJ, Woodruff CE. The loss of tuberculin sensitivity in certain patients with active pulmonary tuberculosis. Chest 1970; 57:530-4.
20. Kardjito T, Donosepoetro M, Grange JM. The Mantoux test in tuberculosis: correlations between the diameters of the dermal responses and the serum protein levels. Tubercle 1981; 62:31-5.
21. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107:837-42.
22. Pai M, Lewinsohn DM. Interferon-γ assays for tuberculosis: is anergy the Achilles' heel? Am J Respir Crit Care Med 2005; 172:519-21.
23. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54:49-55.
24. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione M. International standards for tuberculosis care. Lancet Infect Dis 2006; 6: 710-25.
25. Dheda K, Lalvani A, Miller RF, et al. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005; 19:2038-41.
26. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-203.
27. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006; 7:56.